Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,079 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

NCT01393964

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Investigative Clinical Research Of Indiana, Llc Indianapolis, Indiana, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • University Of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

NCT02842229

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +28 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Durán I Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Parc Taulí Sabadell, Barcelona, Spain
  • C.H. Universitario A Coruña A Coruña, La Coruña, Spain
View all 15 locations
View Trial Details
Completed

Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

NCT00281983

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
Locations
  • Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada
  • Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany
  • Universitaetsklinikum Essen Essen, Germany
  • Universitaetsklinikum Goettingen Göttingen, Germany
View all 13 locations
View Trial Details
Completed

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

NCT00104923

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +58 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
  • M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
  • Joe Arrington Cancer Research and Treatment Center Lubbock, Texas, United States
View Trial Details
Completed

Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation

NCT01460420

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Medizinische Klinik and Poliklinik II, University Hospital Würzburg, Germany
  • S Giovanni Battista Hospital Torino, Italy
  • Azienda Ospedaliera Universitaria di Udine Udine, Italy
  • Hospital Clinic i Provincial, Barcelona, Spain
View Trial Details

Related conditions